{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:07:31Z","timestamp":1785402451435,"version":"3.56.0"},"reference-count":29,"publisher":"IMR Press","issue":"7","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br. J. Hosp. Med. (Lond)"],"abstract":"<jats:p>Aims\/Background:Most cases of hepatocellular carcinoma (HCC) develop in the setting of chronic liver disease (CLD), usually with chronic inflammation, fibrosis, or cirrhosis. The case aims to highlight a rare presentation without evidence of prior CLD.Case Presentation:An older adult patient with no risk factors for CLD other than type 2 diabetes, overweight, and hypertension presented with high-gradient ascites, splenomegaly and hypersplenism due to portal hypertension. Results:Imaging identified an extensive tumour thrombus extending from the portal vein and hepatic veins to the inferior vena cava and right atrium\u2014adjacent to a liver mass. Alpha-fetoprotein was extremely elevated. Ultrasound-guided core liver needle biopsy of the mass was diagnostic of HCC. Biosynthetic liver functions were preserved, liver imaging did not show cirrhosis or steatosis, and liver tissue adjacent to the tumour showed no CLD.Conclusion:HCC may rarely present with tumour thrombus-associated portal hypertension and ascites, and very rarely arise with no demonstrable background of liver pathology. Absence of demonstrable CLD does not rule out HCC and its complications.<\/jats:p>","DOI":"10.31083\/bjhm56026","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T07:59:43Z","timestamp":1785398383000},"source":"Crossref","is-referenced-by-count":0,"title":["Hepatocellular Carcinoma Presenting With Extensive Portal Vein Tumour Thrombus Without Evidence of Underlying Liver Cirrhosis or Steatosis: A Case Report"],"prefix":"10.31083","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1413-8858","authenticated-orcid":true,"given":"Ami","family":"Schattner","sequence":"first","affiliation":[{"name":"Department of Medicine, Laniado Hospital, 4244916 Netanya, Israel"},{"name":"Faculty of Medicine, Hebrew University-Hadassah, 91120 Jerusalem, Israel"},{"name":"Adelson School of Medicine, Ariel University, 40700 Ariel, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livnat","family":"Uliel","sequence":"additional","affiliation":[{"name":"Adelson School of Medicine, Ariel University, 40700 Ariel, Israel"},{"name":"Department of Imaging, Laniado Hospital, 4244916 Netanya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzhak","family":"Schechtman","sequence":"additional","affiliation":[{"name":"Adelson School of Medicine, Ariel University, 40700 Ariel, Israel"},{"name":"Department of Pathology, Laniado Hospital, 4244916 Netanya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Dubin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Laniado Hospital, 4244916 Netanya, Israel"},{"name":"Adelson School of Medicine, Ariel University, 40700 Ariel, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, et al. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology (Baltimore, Md.). 2023; 78: 1922\u20131965.","DOI":"10.1097\/HEP.0000000000000466"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Phoolchund AGS, Khakoo SI. MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges. Cancers. 2024; 16: 259.","DOI":"10.3390\/cancers16020259"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Vogel A, Chan SL, Dawson LA, Kelley RK, Llovet JM, Meyer T, et al. Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology. 2025; 36: 491\u2013506.","DOI":"10.1016\/j.annonc.2025.02.006"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Biggins SW, Angeli P, Garcia-Tsao G, Gin\u00e8s P, Ling SC, Nadim MK, et al. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology (Baltimore, Md.). 2021; 74: 1014\u20131048.","DOI":"10.1002\/hep.31884"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Reig M, Forner A, Rimola J, Ferrer-F\u00e0brega J, Burrel M, Garcia-Criado \u00c1, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. Journal of Hepatology. 2022; 76: 681\u2013693.","DOI":"10.1016\/j.jhep.2021.11.018"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Boccatonda A, Gentilini S, Zanata E, Simion C, Serra C, Simioni P, et al. Portal Vein Thrombosis: State-of-the-Art Review. Journal of Clinical Medicine. 2024; 13: 1517.","DOI":"10.3390\/jcm13051517"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Tathireddy H, Rice D, Martens K, Shivakumar S, Shatzel J. Breaking down tumor thrombus: Current strategies for medical management. Thrombosis Research. 2023; 230: 144\u2013151.","DOI":"10.1016\/j.thromres.2023.09.004"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, et al. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology. 2009; 137: 110\u2013118.","DOI":"10.1053\/j.gastro.2009.04.005"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Rohatgi S, Howard SA, Tirumani SH, Ramaiya NH, Krajewski KM. Multimodality Imaging of Tumour Thrombus. Canadian Association of Radiologists Journal. 2015; 66: 121\u2013129.","DOI":"10.1016\/j.carj.2014.11.001"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Lu J, Zhang XP, Zhong BY, Lau WY, Madoff DC, Davidson JC, et al. Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west. The Lancet. Gastroenterology & Hepatology. 2019; 4: 721\u2013730.","DOI":"10.1016\/S2468-1253(19)30178-5"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Antonios K, Antonios B, Al-Banaa K, Chisti MM. Anticoagulation for portal vein thrombosis in patients with hepatocellular carcinoma: A retrospective observational study. Journal of Clinical Oncology. 2023; 41: e16212.","DOI":"10.1200\/JCO.2023.41.16_suppl.e16212"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Tapper EB, Parikh ND. Diagnosis and Management of Cirrhosis and Its Complications: A Review. JAMA. 2023; 329: 1589\u20131602.","DOI":"10.1001\/jama.2023.5997"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Kelley RK, Greten TF. Hepatocellular Carcinoma - Origins and Outcomes. The New England Journal of Medicine. 2021; 385: 280\u2013282.","DOI":"10.1056\/NEJMcibr2106594"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Targher G, Valenti L, Byrne CD. Metabolic Dysfunction-Associated Steatotic Liver Disease. The New England Journal of Medicine. 2025; 393: 683\u2013698.","DOI":"10.1056\/NEJMra2412865"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Phan J, Ng V, Sheinbaum A, French S, Choi G, El Kabany M, et al. Hyperlipidemia and Nonalcoholic Steatohepatitis Predispose to Hepatocellular Carcinoma Development Without Cirrhosis. Journal of Clinical Gastroenterology. 2019; 53: 309\u2013313.","DOI":"10.1097\/MCG.0000000000001062"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Jain A, Mazer B, Deng Y, Ciarleglio M, Jain D, Taddei T, et al. Hepatocellular Carcinoma: Does the Background Liver With or Without Cirrhosis Matter? American Journal of Clinical Pathology. 2022; 157: 305\u2013313.","DOI":"10.1093\/ajcp\/aqab125"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Marcellin P, Thiers V, Degott C, Franco D, Belghitti J, Castaing D, et al. Hepatocellular carcinoma with normal adjacent liver. Hepatitis B virus DNA status. Journal of Hepatology. 1989; 8: 249\u2013253.","DOI":"10.1016\/0168-8278(89)90015-9"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Simon TG, King LY, Chong DQ, Nguyen LH, Ma Y, VoPham T, et al. Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies. Hepatology (Baltimore, Md.). 2018; 67: 1797\u20131806.","DOI":"10.1002\/hep.29660"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Singh MK, Das BK, Choudhary S, Gupta D, Patil UK. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management. Biomedicine & Pharmacotherapy. 2018; 106: 991\u20131002.","DOI":"10.1016\/j.biopha.2018.06.095"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Pili\u00e9 PG, Johnson AM, Hanson KL, Dayno ME, Kapron AL, Stoffel EM, et al. Germline genetic variants in men with prostate cancer and one or more additional cancers. Cancer. 2017; 123: 3925\u20133932.","DOI":"10.1002\/cncr.30817"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Hui S, Zeid K, Kou R, Mallick R, Carrier M, Wang TF. Management and outcomes in patients with tumor thrombus: a retrospective cohort study. Journal of Thrombosis and Haemostasis. 2025; 23: 201\u2013209.","DOI":"10.1016\/j.jtha.2024.10.002"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Stella L, De Siati M, Talerico R, Pallozzi M, Cerrito L, Sorrentino S, et al. Thrombotic Risk and Coagulation Imbalance in Cirrhosis and Hepatocellular Carcinoma: Clinical Implications and Management. Cancers. 2025; 17: 3413.","DOI":"10.3390\/cancers17213413"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Zhang M, Ding Q, Bian C, Su J, Xin Y, Jiang X. Progress on the molecular mechanism of portal vein tumor thrombosis formation in hepatocellular carcinoma. Experimental Cell Research. 2023; 426: 113563.","DOI":"10.1016\/j.yexcr.2023.113563"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Li Z, Zhao M, Qi X, Tang Y, Cheng S. Mechanisms of portal vein tumour thrombus formation and development in patients with hepatocellular carcinoma. Journal of Cellular and Molecular Medicine. 2023; 27: 2103\u20132111.","DOI":"10.1111\/jcmm.17808"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Jiang JF, Lao YC, Yuan BH, Yin J, Liu X, Chen L, et al. Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges. Oncotarget. 2017; 8: 33911\u201333921.","DOI":"10.18632\/oncotarget.15411"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Connolly GC, Chen R, Hyrien O, Mantry P, Bozorgzadeh A, Abt P, et al. Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thrombosis Research. 2008; 122: 299\u2013306.","DOI":"10.1016\/j.thromres.2007.10.009"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Donati MB, Lorenzet R. Thrombosis and cancer: 40 years of research. Thrombosis Research. 2012; 129: 348\u2013352.","DOI":"10.1016\/j.thromres.2011.12.022"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Chung I, Lip GYH. Virchow's triad revisited: blood constituents. Pathophysiology of Haemostasis and Thrombosis. 2003; 33: 449\u2013454.","DOI":"10.1159\/000083844"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Park H, Jeong CW, Yuk H, Ku JH, Kim HH, Kwak C, et al. Influence of Tumor Thrombus on Occurrence of Distant Venous Thromboembolism and Survival in Patients With Renal Cell Carcinoma After Surgery. Clinical and Applied Thrombosis\/Hemostasis. 2019; 25: 1076029618823288.","DOI":"10.1177\/1076029618823288"}],"container-title":["British Journal of Hospital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/BJHM\/87\/7\/10.31083\/BJHM56026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T07:59:55Z","timestamp":1785398395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/BJHM\/87\/7\/10.31083\/BJHM56026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"alternative-id":["S1750-8460(26)03339-0"],"URL":"https:\/\/doi.org\/10.31083\/bjhm56026","relation":{},"ISSN":["1750-8460","1759-7390"],"issn-type":[{"value":"1750-8460","type":"print"},{"value":"1759-7390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"article-number":"56026"}}